4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-23-034479
Options or other derivatives
- CEO acquired 3,338,878 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Spoor Johan M. CEO | 2023-12-12 | Grant or award · Stock Options (right to buy) | +3,338,878 | 11,793,635 | D: show line 1 in the form |
Loading xslF345X05/rdgdoc.xml…